GE HealthCare, Flyrcado
US FDA approves GE HealthCare's diagnostic drug for heart disease
The U.S. Food and Drug Administration approved GE HealthCare's diagnostic drug for use in detection of coronary artery disease, the company said on Friday. Flyrcado, which is a radioactive diagnostic drug for positron emission tomography (PET) myocardial perfusion imaging (MPI),
Buy Rating for GE Healthcare on Flyrcado’s Market Potential and FDA Approval
Analyst Larry Biegelsen from Wells Fargo maintained a Buy rating on GE Healthcare Technologies Inc (GEHC – Research Report) and keeping
FDA approves GE Healthcare’s Flyrcado for CAD diagnosis
GE Healthcare Technologies Inc. received U.S. FDA approval for its novel radiotracer, Flyrcado (flurpiridaz F-18), for use in the diagnosis of myocardial ischemia or infarction in patients with known or suspected coronary artery disease.
GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of coronary artery disease
GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of coronary artery disease
GE HealthCare’s Flyrcado PET radiotracer secures FDA approval
Flyrcado is designed for patients with known or suspected CAD, providing a ready-to-use unit dose that can be manufactured offsite. It is expected to improve access to PET MPI, pa
GE HealthCare Stock Likely to Rise After FDA Approval of Flyrcado
GE HealthCare Technologies, Inc. GEHC announced that it has received FDA approval for Flyrcado (flurpiridaz F 18), a breakthrough positron emission tomography myocardial perfusion imaging (PET MPI) agent for detecting coronary artery disease (CAD).
Approval of New Test Agent Lifts GE Healthcare Stock
GE HealthCare shares are up nearly 1% after getting the green light late Friday from U.S. regulators to sell a new diagnostic imaging agent that analysts say could be a big seller for the [General Ele ...
Is GE Healthcare Technologies Inc. (GEHC) the Best Young Stock To Buy Now?
We recently compiled a list of 10 Best Young Stocks To Buy Now. In this article, we will look at where GE Healthcare ...
GE HealthCare cut to sell by UBS over competitive concerns
GE HealthCare (NASDAQ:GEHC) was cut to sell by UBS on Thursday, with the bank asserting that rewards were already priced into ...
FierceBiotech12d
GE HealthCare claims FDA clearance for amyloid imaging software in Alzheimer’s disease
GE HealthCare’s recently acquired MIM Software division has secured an FDA clearance for a tool to help quantify the density ...
Modern Healthcare3d
Top digital health funding: Nvidia invests in Hippocratic AI
Hippocratic AI is developing a generative AI model that aims to help providers complete non-diagnostic and patient-facing ...
MassDevice12d
GE HealthCare picks up FDA nod for new brain imaging tool for Alzheimer’s
The GE HealthCare imaging tool is coming out as pharma companies release new therapies onto the market to help treat the ...
Reuters2d
Health & Pharma News | Latest Healthcare Stories | Reuters
Future of Healthcategory US FDA approves GE HealthCare's diagnostic drug for heart disease September 27, 2024 Healthcare & Pharmaceuticalscategory US farmers call for vaccine option to fight ...
GE HealthCare cut to sell by UBS over Chinese competition concerns
GE HealthCare (GEHC) was cut to sell by UBS on Thursday, with the bank asserting that risks such as increasing Chinese ...
Tech Moves: GE healthcare exec joins startup; Nautilus taps new CMO; WRF investor steps down
Selvan Senthivel is the new chief technology officer for the 6-year-old Seattle startup. Senthivel was most recently CTO for ...